H.C. Wainwright raised the firm’s price target on Balchem (BCPC) to $190 from $185 and keeps a Buy rating on the shares post the Q3 report. The firm continues to consider Balchem a bright spot within the human and animal nutrition and health arena.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BCPC: